SEC Form 4 research
| Issuer | Dyne Therapeutics, Inc. |
|---|---|
| Tickers | DYN |
| Reporting owners | 48 |
| Officers and directors | 14 |
| Last public filing | 2026-10-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-06 | 2026-10-02 | Posner Brian S | P | 2,500 | $16 | Not reported |
| 2026-09-08 | 2026-09-08 | Friedl-Naderer Johanna | S | 185 | $18.88 | Not reported |
| 2026-09-08 | 2026-09-04 | Friedl-Naderer Johanna | S | 900 | $24.35 | Not reported |
| 2026-09-08 | 2026-09-08 | Kerr Douglas | S | 1,290 | $18.88 | Not reported |
| 2026-09-08 | 2026-09-04 | Kerr Douglas | S | 3,745 | $24.35 | Not reported |
| 2026-09-08 | 2026-09-08 | Cox John | S | 5,658 | $18.88 | Not reported |
| 2026-08-17 | 2026-08-13 | Friedl-Naderer Johanna | S | 226 | $26.28 | Not reported |
| 2026-08-17 | 2026-08-13 | Kerr Douglas | S | 1,556 | $26.28 | Not reported |
| 2026-08-17 | 2026-08-13 | Lucera Erick | S | 1,797 | $26.28 | Not reported |
| 2026-08-17 | 2026-08-14 | Rhodes Jason P | S | 322,465 | $25 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.